Search All News
In the last 50 years, the main approaches for treating myelodysplastic syndromes or acute myeloid leukemia have not changed. The Kousteni lab aims to change that.
New awards program supports cutting-edge research dedicated to the study and treatment of MDS, a malignant disease that attacks bone marrow stem cells.
The new Center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.